A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients-Reference-Cited by-同舟云学术

A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients

Published:2004-04 Issue:4 Volume:10 Page:246-258
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Osunkwo Ifeyinwa,Bessmertny Olga,Harrison Lauren,Cheung Ying-Kuen,Van De Ven Carmella,del Toro Gustavo,Garvin James,George Diane,Bradley M.Brigid,Wolownik Karen,Wischhover Cheryl,Levy Joseph,Skerrett Donna,Cairo Mitchell S

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference48 articles.

1. Graft-versus-Host Disease;Chao,1999

2. Acute graft-vs-host disease;Goker;Exp Hematol.,2001

3. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone;Nademanee;Blood,1995

4. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT;Ruutu;Bone Marrow Transplant.,1997

5. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group;Gluckman;N Engl J Med.,1997

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-08

2. External evaluation of a population pharmacokinetic model of tacrolimus after hematopoietic stem cell transplantation in children with thalassemia;2023-08-01

3. Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma;Leukemia & Lymphoma;2022-10-19

4. Analyzing the clinical outcomes of switching from cyclosporine to tacrolimus in pediatric hematopoietic stem cell transplantation;Clinical Transplantation;2021-05-03

5. Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts;Journal of Clinical Pharmacy and Therapeutics;2020-10-22